Synthesis and biological evaluation of allylated and prenylated mono-carbonyl analogs of curcumin as anti-inflammatory agents. 2014

Zhiguo Liu, and Longguang Tang, and Peng Zou, and Yali Zhang, and Zhe Wang, and Qilu Fang, and Lili Jiang, and Gaozhi Chen, and Zheng Xu, and Huajie Zhang, and Guang Liang
Chemical Biology Research Center at School of Pharmaceutical Sciences, Wenzhou Medical University, 1210 University Town, Wenzhou, Zhejiang 325035, China; Wenzhou Undersun Biotechnology Co., Ltd., Wenzhou, Zhejiang, China.

Curcumin has been shown to possess anti-inflammatory activities but has been limited for its low stability and poor bioavailability. We have previously reported four series of 5-carbon linker-containing mono-carbonyl analogs of curcumin (MACs). In continuation of our ongoing research, we designed and synthesized 33 novel allylated or prenylated MACs here, and evaluated their anti-inflammatory effects in RAW 264.7 macrophages. A majority of them effectively inhibited the LPS-induced expression of TNF-α and IL-6, especially IL-6. The preliminary SAR and quantitative SAR analysis were conducted. Compound 14q is the most potent analog among them, and exhibits significant protection against LPS-induced death in septic mice. Together, these data present a series of new analogs of curcumin as promising anti-inflammatory agents.

UI MeSH Term Description Entries
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003474 Curcumin A yellow-orange dye obtained from tumeric, the powdered root of CURCUMA longa. It is used in the preparation of curcuma paper and the detection of boron. Curcumin appears to possess a spectrum of pharmacological properties, due primarily to its inhibitory effects on metabolic enzymes. 1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-, (E,E)-,Curcumin Phytosome,Diferuloylmethane,Mervia,Turmeric Yellow,Phytosome, Curcumin,Yellow, Turmeric
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Zhiguo Liu, and Longguang Tang, and Peng Zou, and Yali Zhang, and Zhe Wang, and Qilu Fang, and Lili Jiang, and Gaozhi Chen, and Zheng Xu, and Huajie Zhang, and Guang Liang
December 2016, Bioorganic & medicinal chemistry letters,
Zhiguo Liu, and Longguang Tang, and Peng Zou, and Yali Zhang, and Zhe Wang, and Qilu Fang, and Lili Jiang, and Gaozhi Chen, and Zheng Xu, and Huajie Zhang, and Guang Liang
June 2013, Bioorganic & medicinal chemistry,
Zhiguo Liu, and Longguang Tang, and Peng Zou, and Yali Zhang, and Zhe Wang, and Qilu Fang, and Lili Jiang, and Gaozhi Chen, and Zheng Xu, and Huajie Zhang, and Guang Liang
October 2016, European journal of medicinal chemistry,
Zhiguo Liu, and Longguang Tang, and Peng Zou, and Yali Zhang, and Zhe Wang, and Qilu Fang, and Lili Jiang, and Gaozhi Chen, and Zheng Xu, and Huajie Zhang, and Guang Liang
February 2014, Journal of enzyme inhibition and medicinal chemistry,
Zhiguo Liu, and Longguang Tang, and Peng Zou, and Yali Zhang, and Zhe Wang, and Qilu Fang, and Lili Jiang, and Gaozhi Chen, and Zheng Xu, and Huajie Zhang, and Guang Liang
July 2004, Bioorganic & medicinal chemistry,
Zhiguo Liu, and Longguang Tang, and Peng Zou, and Yali Zhang, and Zhe Wang, and Qilu Fang, and Lili Jiang, and Gaozhi Chen, and Zheng Xu, and Huajie Zhang, and Guang Liang
February 2008, Bioorganic & medicinal chemistry letters,
Zhiguo Liu, and Longguang Tang, and Peng Zou, and Yali Zhang, and Zhe Wang, and Qilu Fang, and Lili Jiang, and Gaozhi Chen, and Zheng Xu, and Huajie Zhang, and Guang Liang
November 2015, Bioorganic & medicinal chemistry,
Zhiguo Liu, and Longguang Tang, and Peng Zou, and Yali Zhang, and Zhe Wang, and Qilu Fang, and Lili Jiang, and Gaozhi Chen, and Zheng Xu, and Huajie Zhang, and Guang Liang
September 2017, Future medicinal chemistry,
Zhiguo Liu, and Longguang Tang, and Peng Zou, and Yali Zhang, and Zhe Wang, and Qilu Fang, and Lili Jiang, and Gaozhi Chen, and Zheng Xu, and Huajie Zhang, and Guang Liang
September 2023, Molecules (Basel, Switzerland),
Zhiguo Liu, and Longguang Tang, and Peng Zou, and Yali Zhang, and Zhe Wang, and Qilu Fang, and Lili Jiang, and Gaozhi Chen, and Zheng Xu, and Huajie Zhang, and Guang Liang
January 2014, Drug design, development and therapy,
Copied contents to your clipboard!